(Q24241123)

English

Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitis

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitis (English)

0 references

1 reference

1 reference

Brian W Behm

1

0 references

Stephen J Bickston

series ordinal

2

0 references

publication date

21 January 2009

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

21 January 2018

Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

21 January 2018

Natalizumab for induction of remission in Crohn's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

21 January 2018

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

21 January 2018

Cyclosporine A for induction of remission in severe ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

21 January 2018

Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

21 January 2018

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

21 January 2018

Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD007571

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD007571

0 references

PubMed publication ID

19160337

0 references

(Q24241123)

Humanized antibody to the alpha4beta7 integrin for induction of remission in ulcerative colitis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)